首页> 外文会议>UKSim-AMSS 11th European Modelling Symposium on Computer Modelling and Simulation >An Integrative Omics Approach to Identify Sub-Network Biomarker in Type 2 Diabetes Mellitus
【24h】

An Integrative Omics Approach to Identify Sub-Network Biomarker in Type 2 Diabetes Mellitus

机译:一种综合的组学方法来识别2型糖尿病的子网络生物标志物

获取原文

摘要

In its most ambitious form, integrated multi-omics data technique aims to discover robust prognostic molecular signatures as disease biomarkers. Although, a massive collection of computational analysis approaches has emerged gradually for identifying genes or pathways (groups of genes) that contribute to diseases and other biological processes; gene expression values and confidence score/strength of interactions are hardly used in scoring/ranking the resulting pathways. We have introduced a simple but efficient approach for identifying subnetwork biomarkers can discriminate diseases versus control stage using readily available topological and network information. The procedure is applied to type 2 diabetes mellitus (T2DM) as a case study. We discover a novel gene signatures biomarker from mRNA expression data in skeletal muscle for T2DM. The resulting biomarker is highly enriched with related T2DM pathways and causal genes. Further, the identified subnetwork biomarker outperformed other well-known biokmakers in classification performance and has consistently high accuracies across different tissues and experiments. Taken together, the proposed approach proves the facility of identifying an accurate biomarker for T2DM disease prognosis due to the inclusion of important topological and network information in scoring the resulting pathways. Moreover, it could be successfully employed in biomarker discovery for further studies that characterized by expression profiles.
机译:集成多组学数据技术以其最雄心勃勃的形式,旨在发现作为疾病生物标记物的可靠的预后分子标记。虽然,已经逐渐出现了大量的计算分析方法,用于识别导致疾病和其他生物过程的基因或途径(基因组)。基因表达值和相互作用的置信度得分/强度几乎没有用于对所得途径进行评分/排序。我们已经介绍了一种简单而有效的方法,可以使用易于获得的拓扑和网络信息来识别子网生物标记物,以区分疾病和控制阶段。该程序适用于2型糖尿病(T2DM)。我们从T2DM的骨骼肌中的mRNA表达数据中发现了一种新型的基因签名生物标志物。产生的生物标记物高度富含相关的T2DM途径和因果基因。此外,所识别的子网生物标记物在分类性能方面优于其他知名的生物标记物,并且在不同组织和实验中始终具有较高的准确性。综上所述,由于在计分所得途径中包含了重要的拓扑和网络信息,因此所提出的方法证明了为T2DM疾病预后确定准确的生物标志物的便利。而且,它可以成功地用于生物标志物的发现,以进行以表达谱为特征的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号